INNOKEYS
Innokeys is a Singapore based biotechnology company founded in 2012 with the aim of developing and commercializing innovations that fulfill unmet medical needs in oncology. Together with InnoCIMAB and CIMAB, Innokeys is currently coordinating the global development activities of nimotuzumab, an anti-EGFR monoclonal antibody to treat solid cancers of epithelial origin. Nimotuzumab was invented in Cuba by the Center of Molecular Immunology (CIM) and was licensed to CIMYM, a subsidiary of YM Biosci... ences (Canada) for early clinical development before the license was acquired by Innokeys in 2012. Late stage clinical development is now being carried out globally by various partners in different indications, including head and neck cancer, pancreatic cancer, gastric cancer, cervical cancer and others. Currently nimotuzumab is already approved in more than 30 countries world-wide.
INNOKEYS
Social Links:
Industry:
Biotechnology
Founded:
2012-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.innokeys.com
Total Employee:
11+
Status:
Active
Contact:
+65 6570 5317
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome Apache
Similar Organizations
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
Current Advisors List
Official Site Inspections
http://www.innokeys.com Semrush global rank: 5.07 M Semrush visits lastest month: 737
- Host name: apache2-fritz.pdx1-shared-a1-26.dreamhost.com
- IP address: 69.163.180.217
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
